Ronald L. Stotish, Ph.D. is CEO, President and Executive Director of Aqua Bounty Technologies. Ron joined AquaBounty in 2006 as Vice President for Regulatory Affairs. Prior to joining Aqua Bounty, Ron was Executive Vice President for R&D at MetaMorphix, Inc. He previously served as Vice President for Global Pharmaceutical Research and Development at Fort Dodge Animal Health, and held a variety of positions at American Cyanamid. He began his career in basic research at Merck. Ron has degrees in Biochemistry and over forty-five years experience in the discovery, development, and commercialization of new animal health products. Ron is a member of the Board of Directors of BIO, the Biotechnology Innovation Organization, and serves on the Food and Agriculture Section Governing Board of BIO as well as the Animal Policy Committee. He is a member of the World Aquaculture Society, Global Aquaculture Alliance, the American Association for the Advancement of Science, and the National Institute for Animal Agriculture.